» Authors » Daniel Rodrigo-Torres

Daniel Rodrigo-Torres

Explore the profile of Daniel Rodrigo-Torres including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 776
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gadd V, Ferreira-Gonzalez S, Man T, Kilpatrick A, Aird R, Smith I, et al.
J Hepatol . 2025 Jan; PMID: 39755157
Background & Aims: Hepatocyte transplantation has shown promise for genetic diseases of the hepatocytes but to date has shown limited efficacy for non-genetic forms of severe liver injury. Limited cell...
2.
Selem-Mojica N, Karakulak T, Anjum A, Pashkov A, Perez-Estrada R, Enriquez-Guillen K, et al.
Bioinformatics . 2024 Jun; 40(Suppl 1):i11-i19. PMID: 38940154
Motivation: Wikipedia is a vital open educational resource in computational biology. The quality of computational biology coverage in English-language Wikipedia has improved steadily in recent years. However, there is an...
3.
Esser H, Kilpatrick A, Man T, Aird R, Rodrigo-Torres D, Buch M, et al.
J Hepatol . 2024 Jun; 81(6):1005-1022. PMID: 38879173
Background & Aims: Biliary complications are a major cause of morbidity and mortality in liver transplantation. Up to 25% of patients that develop biliary complications require additional surgical procedures, re-transplantation...
4.
Li B, Rodrigo-Torres D, Pelz C, Innes B, Canaday P, Chai S, et al.
bioRxiv . 2023 Jul; PMID: 37503083
In solid tissues homeostasis and regeneration after injury involve a complex interplay between many different cell types. The mammalian liver harbors numerous epithelial and non-epithelial cells and little is known...
5.
Ferreira-Gonzalez S, Man T, Esser H, Aird R, Kilpatrick A, Rodrigo-Torres D, et al.
Sci Transl Med . 2022 Dec; 14(674):eabj4375. PMID: 36475903
Liver transplantation is the only curative option for patients with end-stage liver disease. Despite improvements in surgical techniques, nonanastomotic strictures (characterized by the progressive loss of biliary tract architecture) continue...
6.
Hallett J, Ferreira-Gonzalez S, Man T, Kilpatrick A, Esser H, Thirlwell K, et al.
Cell Stem Cell . 2022 Mar; 29(3):355-371.e10. PMID: 35245467
Biliary diseases can cause inflammation, fibrosis, bile duct destruction, and eventually liver failure. There are no curative treatments for biliary disease except for liver transplantation. New therapies are urgently required....
7.
Blaya D, Rubio-Tomas T, Rodrigo-Torres D, Lozano J, Coll M, Argemi J, et al.
Hepatol Int . 2021 May; 15(4):1006-1017. PMID: 33954832
Objectives: Alcoholic hepatitis (AH) is a severe condition characterized by a marked inflammatory response and high short-term mortality. Endothelial dysfunction (ED) is an early event in vascular and inflammatory disorders....
8.
Ferreira-Gonzalez S, Rodrigo-Torres D, Gadd V, Forbes S
Semin Liver Dis . 2021 Mar; 41(1):50-66. PMID: 33764485
Cellular senescence is an irreversible cell cycle arrest implemented by the cell as a result of stressful insults. Characterized by phenotypic alterations, including secretome changes and genomic instability, senescence is...
9.
Aguilar-Bravo B, Rodrigo-Torres D, Arino S, Coll M, Pose E, Blaya D, et al.
Hepatology . 2018 Dec; 69(5):2180-2195. PMID: 30565271
Chronic liver diseases are characterized by the expansion of ductular reaction (DR) cells and the expression of liver progenitor cell (LPC) markers. In alcoholic hepatitis (AH), the degree of DR...
10.
Coll M, Perea L, Boon R, Leite S, Vallverdu J, Mannaerts I, et al.
Cell Stem Cell . 2018 Jul; 23(1):101-113.e7. PMID: 30049452
The development of complex in vitro hepatic systems and artificial liver devices has been hampered by the lack of reliable sources for relevant cell types, such as hepatic stellate cells...